{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:50:45Z","timestamp":1793332245916,"version":"4.5.0"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014824","name":"Government of India Department of Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijbiomac.2026.151150","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T17:45:40Z","timestamp":1772473540000},"page":"151150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Neurofilament light chain protein exposure contributes to protein aggregation, microgliosis, astrogliosis and neuroinflammation via p38\/MK2\/NF-\u03baB\/CREB1\/Nrf2\/HO-1 signalling leading to Parkinson's disease"],"prefix":"10.1016","volume":"353","author":[{"given":"Anjuman","family":"Nanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivam Kumar","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151150_bb0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00429-025-02959-9","article-title":"Temporal progression of pathological features in an \u03b1-synuclein overexpression model of Parkinson\u2019s disease","volume":"230","author":"Vaquero-Rodr\u00edguez","year":"2025","journal-title":"Brain Struct. Funct."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151150_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2025.103735","article-title":"Unraveling synucleinopathies: recent breakthroughs in Parkinson\u2019s disease therapy","volume":"392","author":"Nanda","year":"2025","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151150_bb0015","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/mds.28056","article-title":"CSF NFL in a longitudinally assessed PD cohort: age effects and cognitive trajectories","volume":"35","author":"Lerche","year":"2020","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151150_bb0020","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","article-title":"Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder","volume":"88","author":"Hansson","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2016.05.018","article-title":"Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases","volume":"91","author":"Bacioglu","year":"2016","journal-title":"Neuron"},{"issue":"11\u221212","key":"10.1016\/j.ijbiomac.2026.151150_bb0030","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1089\/neu.2022.0252","article-title":"Acute blood levels of Neurofilament light indicate one-year white matter pathology and functional impairment in repetitive mild traumatic brain injured mice","volume":"40","author":"Moro","year":"2023","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0035","article-title":"Evaluation of serum NFL, T-tau, p-tau181, p-tau217, A\u00df40 and A\u00df42 for the diagnosis of neurodegenerative diseases","author":"Kahouadji","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0040","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fnagi.2020.00128","article-title":"Increased CSF NFL in non-demented Parkinson\u2019s disease subjects reflects early white matter damage","volume":"12","author":"Papu\u0107","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0045","doi-asserted-by":"crossref","DOI":"10.1177\/17562864251324406","article-title":"The potential use of plasma NfL as a diagnostic and prognostic biomarker of fatigue in early Parkinson\u2019s disease","volume":"18","author":"Che","year":"2025","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41531-025-00951-y","article-title":"Head-to-head comparison of four cerebrospinal fluid and three plasma neurofilament light chain assays in Parkinsonism","volume":"11","author":"Baiardi","year":"2025","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41531-021-00232-4","article-title":"Neurofilament light chain and \u03b1-synuclein RT-QuIC as differential diagnostic biomarkers in Parkinsonisms and related syndromes","volume":"7","author":"Quadalti","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"issue":"4\u20135","key":"10.1016\/j.ijbiomac.2026.151150_bb0060","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.brainresbull.2009.06.004","article-title":"Neuronal intermediate filaments and neurodegenerative disorders","volume":"80","author":"Perrot","year":"2009","journal-title":"Brain Res. Bull."},{"issue":"7\u20138","key":"10.1016\/j.ijbiomac.2026.151150_bb0065","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/cm.21566","article-title":"Charcot-Marie-tooth disease type 2E\/1F mutant neurofilament proteins assemble into neurofilaments","volume":"76","author":"Stone","year":"2019","journal-title":"Cytoskeleton (Hoboken)"},{"issue":"19","key":"10.1016\/j.ijbiomac.2026.151150_bb0070","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/hmg\/ddh236","article-title":"Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-tooth disease in cell culture models","volume":"13","author":"Perez-Olle","year":"2004","journal-title":"Hum. Mol. Genet."},{"issue":"13","key":"10.1016\/j.ijbiomac.2026.151150_bb0075","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1093\/hmg\/ddq149","article-title":"Reversal of neuropathy phenotypes in conditional mouse model of Charcot-Marie-tooth disease type 2E","volume":"19","author":"Dequen","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"29","key":"10.1016\/j.ijbiomac.2026.151150_bb0080","doi-asserted-by":"crossref","first-page":"10351","DOI":"10.1073\/pnas.0503862102","article-title":"Altered axonal architecture by removal of the heavily phosphorylated neurofilament tail domains strongly slows superoxide dismutase 1 mutant-mediated ALS","volume":"102","author":"Lobsiger","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.151150_bb0085","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.1523\/JNEUROSCI.21-16-06026.2001","article-title":"Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments","volume":"21","author":"Ishihara","year":"2001","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1086\/302962","article-title":"A new variant of Charcot-Marie-tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene","volume":"67","author":"Mersiyanova","year":"2000","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/neu.10270","article-title":"Functions of intermediate filaments in neuronal development and disease","volume":"58","author":"Lariviere","year":"2004","journal-title":"J. Neurobiol."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.151150_bb0100","doi-asserted-by":"crossref","first-page":"9631","DOI":"10.1073\/pnas.95.16.9631","article-title":"Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant","volume":"95","author":"Williamson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151150_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115382","article-title":"Secreted neurofilament light chain after neuronal damage induces myeloid cell activation and neuroinflammation","volume":"44","author":"Kahn","year":"2025","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151150_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/nu13051583","article-title":"Tocotrienols ameliorate neurodegeneration and motor deficits in the 6-OHDA-induced rat model of parkinsonism: Behavioural and immunohistochemistry analysis","volume":"13","author":"Kumari","year":"2021","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151150_bb0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/14728222.2025.2500421","article-title":"Therapeutic potential of MK2 kinase inhibition in pathogenesis of Parkinson\u2019s disease","volume":"29","author":"Nanda","year":"2025","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41531-025-00926-z","article-title":"Disruption of axonal transport in Parkinson's disease: the role of pathological \u03b1-Syn and AMPK\/p38 MAPK signaling","volume":"11","author":"Yang","year":"2025","journal-title":"NPJ Parkinsons Dis"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151150_bb0125","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/j.1471-4159.2008.05310.x","article-title":"Mapkap kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation--relevance in a mouse model of Parkinson\u2019s disease","volume":"105","author":"Thomas","year":"2008","journal-title":"J. Neurochem."},{"issue":"3\u20134","key":"10.1016\/j.ijbiomac.2026.151150_bb0130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/09727531211051976","article-title":"Pharmacological, biochemical and immunological studies on protective effect of Mangiferin in 6-Hydroxydopamine (6-OHDA)-induced Parkinson\u2019s disease in rats","volume":"28","author":"Tiwari","year":"2021","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cbi.2017.10.019","article-title":"Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson\u2019s disease: involvement of neuroinflammation and neurotrophins","volume":"279","author":"Goes","year":"2018","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0140","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/s41598-023-29287-4","article-title":"Oleuropein confers neuroprotection against rotenone-induced model of Parkinson\u2019s disease via BDNF\/CREB\/Akt pathway","volume":"13","author":"Singh","year":"2023","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.ijbiomac.2026.151150_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27227951","article-title":"Effect of natural Adenylcyclase\/cAMP\/CREB Signalling activator Forskolin against intra-striatal 6-OHDA-lesioned Parkinson\u2019s rats: preventing mitochondrial, motor and histopathological defects","volume":"27","author":"Alharbi","year":"2022","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151150_bb0150","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1007\/s11064-020-03067-2","article-title":"Polyphenols from Toona sinensiss seeds alleviate Neuroinflammation induced by 6-Hydroxydopamine through suppressing p38 MAPK signaling pathway in a rat model of Parkinson\u2019s disease","volume":"45","author":"Zhuang","year":"2020","journal-title":"Neurochem. Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151150_bb0155","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1039\/D0FO02836C","article-title":"Schisandra chinensis protects against dopaminergic neuronal oxidative stress, neuroinflammation and apoptosis via the BDNF\/Nrf2\/NF-\u03baB pathway in 6-OHDA-induced Parkinson\u2019s disease mice","volume":"12","author":"Yan","year":"2021","journal-title":"Food Funct."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151150_bb0160","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1471-4159.2008.05864.x","article-title":"The CREB\/CRE transcriptional pathway: protection against oxidative stress-mediated neuronal cell death","volume":"108","author":"Lee","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0165","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fnins.2020.00579","article-title":"Neurofilament-light chain as biomarker of neurodegenerative and rare diseases with high translational value","volume":"14","author":"Loeffler","year":"2020","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151150_bb0170","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.neuron.2016.07.007","article-title":"Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases","volume":"91","author":"Bacioglu","year":"2016","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0175","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1038\/s41598-023-32480-0","article-title":"Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson\u2019s disease biomarkers using multiplexed single molecule counting","volume":"13","author":"Youssef","year":"2023","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151150_bb0180","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s00415-023-12117-y","article-title":"Relationship between plasma NFL and disease progression in Parkinson\u2019s disease: a prospective cohort study","volume":"271","author":"Ou","year":"2024","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151150_bb0185","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1021\/acs.molpharmaceut.5c00129","article-title":"Bile salts trigger deformability in liposomal vesicles through edge-activating action","volume":"22","author":"Kumar","year":"2025","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151150_bb0190","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s10534-025-00693-7","article-title":"Ferrous sulfate and lipopolysaccharide co-exposure induce neuroinflammation, neurobehavioral motor deficits, neurodegenerative and histopathological biomarkers relevant to Parkinson\u2019s disease-like symptoms in Wistar rats","volume":"38","author":"Pandey","year":"2025","journal-title":"BioMetals"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.151150_bb0195","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.3390\/cells10123548","article-title":"The neuroprotective effects of the CB2 agonist GW842166x in the 6-OHDA mouse model of Parkinson\u2019s disease","volume":"10","author":"Yu","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151150_bb0200","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s10787-023-01141-z","article-title":"Neuroprotective role of chloroquine via modulation of autophagy and neuroinflammation in MPTP-induced Parkinson's disease","volume":"31","author":"Kartik","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fnagi.2018.00237","article-title":"Additive effects of levodopa and a Neurorestorative diet in a mouse model of Parkinson\u2019s disease","volume":"10","author":"Perez-Pardo","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2025.149540","article-title":"Treadmill exercise mitigates rotenone-induced neuroinflammation and \u03b1-synuclein level in a mouse model of Parkinson\u2019s disease","volume":"1854","author":"Kumar","year":"2025","journal-title":"Brain Res."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.151150_bb0215","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1080\/15287394.2025.2470847","article-title":"Neuroprotective effect of Cistanche deserticola glycosides in MPTP-induced Parkinson\u2019s disease mouse model involves Nrf2 activation","volume":"88","author":"Yao","year":"2025","journal-title":"J. Toxicol. Environ. Health A"},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176878","article-title":"The neuroprotective effects of alpha lipoic acid in rotenone-induced Parkinson\u2019s disease in mice via activating PI3K\/AKT pathway and antagonizing related inflammatory cascades","volume":"980","author":"Fahmy","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0225","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.expneurol.2013.03.017","article-title":"Chronic intranasal deferoxamine ameliorates motor defects and pathology in the \u03b1-synuclein rAAV Parkinson\u2019s model","volume":"247","author":"Febbraro","year":"2013","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0230","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1096\/fj.201600751r","article-title":"Neuroprotective effects of fingolimod in mouse models of Parkinson\u2019s disease","volume":"31","author":"Zhao","year":"2017","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151150_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1024","article-title":"Centella asiatica increases hippocampal synaptic density and improves memory and executive function in aged mice","volume":"8","author":"Gray","year":"2018","journal-title":"Brain Behav."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0240","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5214821","article-title":"Misleading westerns: common quantification mistakes in Western blot densitometry and proposed corrective measures","volume":"2019","author":"Butler","year":"2019","journal-title":"Biomed. Res. Int."},{"issue":"50","key":"10.1016\/j.ijbiomac.2026.151150_bb0245","doi-asserted-by":"crossref","first-page":"29692","DOI":"10.1074\/jbc.E115.000002","article-title":"Transparency is the key to quality","volume":"290","author":"Fosang","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0250","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11481-025-10192-8","article-title":"IL-17 a exacerbated neuroinflammatory and neurodegenerative biomarkers in intranasal amyloid-beta model of Alzheimer\u2019s disease","volume":"20","author":"Gautam","year":"2025","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0255","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.freeradbiomed.2025.04.013","article-title":"Betulinic acid protects against lipopolysaccharide and ferrous sulfate-induced oxidative stress, ferroptosis, apoptosis, and neuroinflammation signaling relevant to Parkinson\u2019s disease","volume":"233","author":"Pandey","year":"2025","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151150_bb0260","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1039\/D4FO05278A","article-title":"Therapeutic potential of chrysin in regulation of interleukin-17 signaling in a repeated intranasal amyloid-beta-induced Alzheimer\u2019s disease model","volume":"16","author":"Singh Gautam","year":"2025","journal-title":"Food Funct."},{"issue":"17","key":"10.1016\/j.ijbiomac.2026.151150_bb0265","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1039\/D4FO02602K","article-title":"Quercetin ameliorates neuroinflammatory and neurodegenerative biomarkers in the brain and improves neurobehavioral parameters in a repeated intranasal amyloid-beta exposed model of Alzheimer\u2019s disease","volume":"15","author":"Lasure","year":"2024","journal-title":"Food Funct."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0270","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1567205020666230503141817","article-title":"Roflumilast protects against Neuroinflammatory alterations in brain tissues of lipopolysaccharide-induced mice model","volume":"20","author":"Kumari","year":"2023","journal-title":"Curr. Alzheimer Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151150_bb0275","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1007\/s10753-024-02199-9","article-title":"IL-17A-induced redox imbalance and inflammatory responses in mice lung via Act1-TRAF6-IKB\u03b1 signaling pathway: implications for lung disease pathogenesis","volume":"48","author":"Panda","year":"2024","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0280","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12035-019-01698-3","article-title":"Neurofilament light chain as a biomarker, and correlation with magnetic resonance imaging in diagnosis of CNS-related disorders","volume":"57","author":"Alirezaei","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.689938","article-title":"Neurofilament proteins as biomarkers to monitor neurological diseases and the efficacy of therapies","volume":"15","author":"Yuan","year":"2021","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0290","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13293-025-00692-w","article-title":"Sex and gender differences in the molecular etiology of Parkinson\u2019s disease: considerations for study design and data analysis","volume":"16","author":"Schaffner","year":"2025","journal-title":"Biol. Sex Differ."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151150_bb0295","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.pbb.2010.03.009","article-title":"Sex differences in motor behavior in the MPTP mouse model of Parkinson\u2019s disease","volume":"95","author":"Antzoulatos","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"25","key":"10.1016\/j.ijbiomac.2026.151150_bb0300","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1073\/pnas.1603629113","article-title":"Cross-hemispheric dopamine projections have functional significance","volume":"113","author":"Fox","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151150_bb0305","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2418249122","article-title":"Astrocytes in the mouse brain respond bilaterally to unilateral retinal neurodegeneration","volume":"122","author":"Cooper","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134335","article-title":"Glial response in early stages of traumatic brain injury","volume":"708","author":"Zhao","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0315","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.expneurol.2017.11.003","article-title":"Single severe traumatic brain injury produces progressive pathology with ongoing contralateral white matter damage one year after injury","volume":"300","author":"Pischiutta","year":"2018","journal-title":"Exp. Neurol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151150_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci15080837","article-title":"Contralateral structure and molecular response to severe unilateral brain injury","volume":"15","author":"Liao","year":"2025","journal-title":"Brain Sci."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106761","article-title":"Remodeling of the brain angioarchitecture in experimental chronic neurodegeneration","volume":"204","author":"Thomsen","year":"2025","journal-title":"Neurobiol. Dis."},{"issue":"19","key":"10.1016\/j.ijbiomac.2026.151150_bb0330","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1111\/febs.14587","article-title":"Crucial role of protein oligomerization in the pathogenesis of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"285","author":"Choi","year":"2018","journal-title":"FEBS J."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151150_bb0335","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"28","key":"10.1016\/j.ijbiomac.2026.151150_bb0340","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1073\/pnas.1721220115","article-title":"Identification and nanomechanical characterization of the fundamental single-strand protofilaments of amyloid \u03b1-synuclein fibrils","volume":"115","author":"Ruggeri","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151150_bb0345","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1021\/acschemneuro.1c00797","article-title":"Angiotensin-converting enzyme 2 activation mitigates behavioral deficits and Neuroinflammatory burden in 6-OHDA induced experimental models of Parkinson\u2019s disease","volume":"13","author":"Gupta","year":"2022","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0350","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","article-title":"Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion","volume":"73","author":"Matsuura","year":"1997","journal-title":"J. Neurosci. Methods"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2005.02.023","article-title":"Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson\u2019s disease in mice","volume":"162","author":"Iancu","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0360","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbr.2016.03.019","article-title":"Neurosteroid allopregnanolone attenuates cognitive dysfunctions in 6-OHDA-induced rat model of Parkinson\u2019s disease","volume":"305","author":"Nezhadi","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151150_bb0365","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70008","article-title":"Challenges and opportunities in exploring non-motor symptoms in 6-hydroxydopamine models of Parkinson\u2019s disease: a systematic review","volume":"169","author":"Prates-Rodrigues","year":"2025","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151150_bb0370","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/jamaneurol.2018.3746","article-title":"Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders","volume":"76","author":"Olsson","year":"2019","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151150_bb0375","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1007\/s11030-025-11120-x","article-title":"Discovery of novel A2AR antagonist via 3D-QSAR pharmacophore modeling: neuroprotective effects in 6-OHDA-induced SH-SY5Y cells and haloperidol-induced parkinsonism in C57 bl\/6 mice","volume":"29","author":"Singh","year":"2025","journal-title":"Mol. Divers."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151150_bb0380","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s10787-025-01709-x","article-title":"Therapeutic effect of formononetin in 6-OHDA induced Parkinson disease in rats","volume":"33","author":"Pingale","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151150_bb0385","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70401","article-title":"Neurogrit gold attenuates 6-OHDA-induced dopaminergic neurodegeneration in Parkinson\u2019s model of Caenorhabditis elegans by reducing \u03b1-Synuclein accumulation and pink\/Pdr-1 driven mitochondrial dysfunction","volume":"31","author":"Balkrishna","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2021.102114","article-title":"DJ-1 in neurodegenerative diseases: pathogenesis and clinical application","volume":"204","author":"Huang","year":"2021","journal-title":"Prog. Neurobiol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151150_bb0395","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1021\/acschemneuro.4c00875","article-title":"Exploration of the therapeutic potential of the epigenetic modulator Decitabine on 6-OHDA-induced experimental models of Parkinson\u2019s disease","volume":"16","author":"Kumari","year":"2025","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0400","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neulet.2009.08.023","article-title":"NeuN is not a reliable marker of dopamine neurons in rat substantia nigra","volume":"464","author":"Cannon","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0405","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbr.2011.11.027","article-title":"Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites","volume":"228","author":"Heuer","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151150_bb0410","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.neuroscience.2008.02.033","article-title":"Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson\u2019s disease","volume":"153","author":"Tian","year":"2008","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0415","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.expneurol.2012.02.012","article-title":"Comparison of the behavioural and histological characteristics of the 6-OHDA and \u03b1-synuclein rat models of Parkinson\u2019s disease","volume":"235","author":"Decressac","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0420","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fnmol.2018.00165","article-title":"Simvastatin inhibits activation of NADPH oxidase\/p38 MAPK pathway and enhances expression of antioxidant protein in Parkinson disease models","volume":"11","author":"Tong","year":"2018","journal-title":"Front. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151150_bb0425","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/j.1471-4159.2007.05115.x","article-title":"6-Hydroxydopamine activates the mitochondrial apoptosis pathway through p38 MAPK-mediated, p53-independent activation of Bax and PUMA","volume":"104","author":"Gomez-Lazaro","year":"2008","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151150_bb0430","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1745-7254.2008.00787.x","article-title":"Bilobalide inhibits 6-OHDA-induced activation of NF-kappaB and loss of dopaminergic neurons in rat substantia nigra","volume":"29","author":"Li","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151150_bb0435","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1007\/s11033-021-06343-8","article-title":"Pramipexole attenuates 6-OHDA-induced Parkinson\u2019s disease by mediating the Nurr1\/NF-\u03baB pathway","volume":"48","author":"Gao","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0440","article-title":"Inflammatory hallmarks in 6-OHDA- and LPS-induced Parkinson's disease in rats","volume":"30","author":"Oliynyk","year":"2023","journal-title":"Brain Behav Immun Health"},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.151150_bb0445","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1007\/s12035-020-01940-3","article-title":"Hesperidin ameliorates anxiety-depressive-like behavior in 6-OHDA model of Parkinson\u2019s disease by regulating striatal cytokine and neurotrophic factors levels and dopaminergic innervation loss in the striatum of mice","volume":"57","author":"Antunes","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151150_bb0450","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/rej.2024.0045","article-title":"Luteolin exhibits anxiolytic and antidepressant potential in Parkinson\u2019s disease rat: antioxidant and anti-inflammatory effects","volume":"28","author":"She","year":"2025","journal-title":"Rejuvenation Res."},{"issue":"13","key":"10.1016\/j.ijbiomac.2026.151150_bb0455","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/WNR.0b013e328364d616","article-title":"Hyperphosphorylation of CREB in human dopaminergic neurons: a kinetic study of cellular distribution of total CREB and phospho-CREB following oxidative stress","volume":"24","author":"Ahmed","year":"2013","journal-title":"Neuroreport"},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0460","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bcp.2018.01.047","article-title":"Angiotensin 1-7 ameliorates 6-hydroxydopamine lesions in hemiparkinsonian rats through activation of MAS receptor\/PI3K\/Akt\/BDNF pathway and inhibition of angiotensin II type-1 receptor\/NF-\u03baB axis","volume":"151","author":"Rabie","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151150_bb0465","article-title":"Clinical and mechanistic exploration of Ellagic acid in neurodegenerative diseases: targeted neuroprotection through cellular and molecular mechanisms","volume":"22","author":"Islam","year":"2025","journal-title":"Chem. Biodivers."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.151150_bb0470","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.biopsych.2007.04.020","article-title":"Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson\u2019s disease through inhibition of ROS-NO pathway","volume":"62","author":"Guo","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.151150_bb0475","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1007\/s11064-017-2379-5","article-title":"Neuroprotective activities of Spirulina platensis in the 6-OHDA model of Parkinson\u2019s disease are related to its anti-inflammatory effects","volume":"42","author":"Lima","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0480","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brainres.2010.02.031","article-title":"Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson\u2019s disease","volume":"1328","author":"Khan","year":"2010","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0485","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11064-025-04628-z","article-title":"Schisanhenol inhibits MPTP\/MPP(+)-induced Ferroptosis in dopaminergic neurons via Nrf2\/TrxR1\/GPX4 pathway against Parkinson\u2019s disease","volume":"51","author":"Dong","year":"2025","journal-title":"Neurochem. Res."},{"issue":"8\u20139","key":"10.1016\/j.ijbiomac.2026.151150_bb0490","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1080\/10715762.2025.2565686","article-title":"Betulinic acid protects SH-SY5Y cells exposed to lipopolysaccharide and ferrous sulfate through p38MAPK\/NF-\u03baB\/GPX4\/Nrf2\/keap-1\/HO-1 signaling axis","volume":"59","author":"Pandey","year":"2025","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.115084","article-title":"Acteoside alleviates salsolinol-induced Parkinson\u2019s disease by inhibiting ferroptosis via activating Nrf2\/SLC7A11\/GPX4 pathway","volume":"385","author":"Wang","year":"2025","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102035","article-title":"Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases","volume":"91","author":"Wang","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151150_bb0505","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s11064-015-1751-6","article-title":"Neuroprotective effects of Tanshinone I against 6-OHDA-induced oxidative stress in cellular and mouse model of Parkinson\u2019s disease through upregulating Nrf2","volume":"41","author":"Jing","year":"2016","journal-title":"Neurochem. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151150_bb0510","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s11064-012-0965-0","article-title":"Probucol affords neuroprotection in a 6-OHDA mouse model of Parkinson\u2019s disease","volume":"38","author":"Ribeiro","year":"2013","journal-title":"Neurochem. Res."},{"issue":"11\u201312","key":"10.1016\/j.ijbiomac.2026.151150_bb0515","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.nut.2014.03.024","article-title":"Protective effect of hesperidin in a model of Parkinson\u2019s disease induced by 6-hydroxydopamine in aged mice","volume":"30","author":"Antunes","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110739","article-title":"Oral administration of Limonin (LM) exerts neuroprotective effects by inhibiting neuron autophagy and microglial activation in 6-OHDA-injected rats","volume":"123","author":"Gao","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0525","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainresbull.2022.06.013","article-title":"Enteric glial cell reactivity in colonic layers and mucosal modulation in a mouse model of Parkinson\u2019s disease induced by 6-hydroxydopamine","volume":"187","author":"Thomasi","year":"2022","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0530","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuroscience.2017.08.023","article-title":"An altered blood-brain barrier contributes to brain iron accumulation and neuroinflammation in the 6-OHDA rat model of Parkinson's disease","volume":"362","author":"Olmedo-D\u00edaz","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0535","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/6686037","article-title":"Oral administration of Lactobacillus inhibits the permeability of blood-brain and gut barriers in a parkinsonism model","volume":"2023","author":"N\u00e1poles-Medina","year":"2023","journal-title":"Behav. Neurol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151150_bb0540","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neures.2008.09.001","article-title":"Differential astroglial activation in 6-hydroxydopamine models of Parkinson\u2019s disease","volume":"62","author":"Henning","year":"2008","journal-title":"Neurosci. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151150_bb0545","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1471-4159.2009.06001.x","article-title":"Enriched environment protects the nigrostriatal dopaminergic system and induces astroglial reaction in the 6-OHDA rat model of Parkinson\u2019s disease","volume":"109","author":"Anastas\u00eda","year":"2009","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151150_bb0550","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s10072-011-0925-5","article-title":"Exercise improves motor deficits and alters striatal GFAP expression in a 6-OHDA-induced rat model of Parkinson\u2019s disease","volume":"33","author":"Dutra","year":"2012","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.151150_bb0555","doi-asserted-by":"crossref","DOI":"10.1155\/bn\/8401392","article-title":"Supplementation of the probiotic LLH135 reduces oxidative stress in a model of Hemiparkinsonism","volume":"2025","author":"Flores-Soto","year":"2025","journal-title":"Behav. Neurol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-019-00104-z","article-title":"Differential effects of LPS and 6-OHDA on microglia\u2019s morphology in rats: implications for inflammatory model of Parkinson\u2019s disease","volume":"37","author":"Parra","year":"2020","journal-title":"Neurotox. Res."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151150_bb0565","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1007\/s11033-023-08561-8","article-title":"Repetitive transcranial magnetic stimulation alleviates glial activation through suppressing HMGB1\/TLR4 pathway in a rat model of Parkinson\u2019s disease","volume":"50","author":"Han","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0570","doi-asserted-by":"crossref","first-page":"8795","DOI":"10.1038\/s41598-017-09257-3","article-title":"Targeted inhibition of RAGE in substantia nigra of rats blocks 6-OHDA-induced dopaminergic denervation","volume":"7","author":"Gasparotto","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0575","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneumeth.2004.10.004","article-title":"Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson\u2019s disease","volume":"144","author":"Yuan","year":"2005","journal-title":"J. Neurosci. Methods"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151150_bb0580","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41531-025-00872-w","article-title":"Mapping of catecholaminergic denervation, neurodegeneration, and inflammation in 6-OHDA-treated Parkinson's disease mice","volume":"11","author":"Santoro","year":"2025","journal-title":"NPJ Parkinsons Dis"},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.151150_bb0585","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1016\/j.neurobiolaging.2015.08.024","article-title":"Aging causes morphological alterations in astrocytes and microglia in human substantia nigra pars compacta","volume":"36","author":"Jyothi","year":"2015","journal-title":"Neurobiol. Aging"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026010767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026010767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:41:28Z","timestamp":1777484488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026010767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":117,"alternative-id":["S0141813026010767"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151150","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofilament light chain protein exposure contributes to protein aggregation, microgliosis, astrogliosis and neuroinflammation via p38\/MK2\/NF-\u03baB\/CREB1\/Nrf2\/HO-1 signalling leading to Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151150"}}